<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <laws />
    <notes />
    <billNumber>6284</billNumber>
    <originChamber>House</originChamber>
    <billType>HR</billType>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects />
      </billSubjects>
    </subjects>
    <titles>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>EPI Act</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>Eliminate Price Increases Act of 2016</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>EPI Act</title>
      </item>
    </titles>
    <calendarNumbers />
    <cosponsors />
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2016-09-28</actionDate>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <links />
        <type>IntroReferral</type>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
      </item>
      <item>
        <actionDate>2016-09-28</actionDate>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <committee />
      </item>
      <item>
        <actionDate>2016-09-28</actionDate>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <committee />
      </item>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
    </actions>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 162, Number 147 (Wednesday, September 28, 2016)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. SMITH of Washington:H.R. 6284.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H6107]</pre>]]></constitutionalAuthorityStatementText>
    <cboCostEstimates />
    <version>1.0.0</version>
    <relatedBills />
    <recordedVotes />
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2016-09-28</actionDate>
          <lastSummaryUpdateDate>2016-11-02T11:16:55Z</lastSummaryUpdateDate>
          <updateDate>2016-09-28T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in House</actionDesc>
          <text><![CDATA[<p><b>Eliminate Price Increases Act of 2016 or the EPI Act</b> </p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer. </p>]]></text>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <subcommittees />
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2016-09-28T14:05:15Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <title>EPI Act</title>
    <introducedDate>2016-09-28</introducedDate>
    <createDate>2016-09-29T07:31:04Z</createDate>
    <latestAction>
      <actionDate>2016-09-28</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <links />
    </latestAction>
    <amendments />
    <sponsors>
      <item>
        <party>D</party>
        <middleName />
        <lastName>SMITH</lastName>
        <identifiers>
          <lisID>1528</lisID>
          <gpoId>8213</gpoId>
          <bioguideId>S000510</bioguideId>
        </identifiers>
        <state>WA</state>
        <byRequestType />
        <fullName>Rep. Smith, Adam [D-WA-9]</fullName>
        <bioguideId>S000510</bioguideId>
        <firstName>ADAM</firstName>
        <district>9</district>
      </item>
    </sponsors>
    <congress>114</congress>
    <updateDate>2018-11-21T21:23:53Z</updateDate>
    <committeeReports />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

